Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 13, 2023

SELL
$1.19 - $2.09 $292,628 - $513,943
-245,906 Reduced 65.6%
128,976 $162,000
Q4 2022

Jan 23, 2023

BUY
$1.67 - $2.35 $30,176 - $42,464
18,070 Added 5.06%
374,882 $0
Q3 2022

Oct 26, 2022

SELL
$1.81 - $2.76 $483,009 - $736,522
-266,856 Reduced 42.79%
356,812 $688,000
Q2 2022

Jul 25, 2022

BUY
$1.34 - $5.34 $356,701 - $1.42 Million
266,195 Added 74.47%
623,668 $1.3 Million
Q1 2022

May 02, 2022

BUY
$4.58 - $6.8 $171,090 - $254,020
37,356 Added 11.67%
357,473 $1.64 Million
Q4 2021

Jan 28, 2022

BUY
$5.23 - $7.18 $1.67 Million - $2.3 Million
320,117 New
320,117 $2.06 Million

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.